Antithymocyte globulin and transplants for aplastic anemia.
作者信息
Bacigalupo Andrea
机构信息
Istituto di Ematologia, Universita' Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A Gemelli, Rome, Italy
出版信息
Haematologica. 2017 Jul;102(7):1137-1138. doi: 10.3324/haematol.2017.171538.
Abstract
摘要
相似文献
1
Antithymocyte globulin and transplants for aplastic anemia.抗胸腺细胞球蛋白与再生障碍性贫血的移植治疗
Haematologica. 2017 Jul;102(7):1137-1138. doi: 10.3324/haematol.2017.171538.
2
Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.兔抗胸腺细胞球蛋白和马抗胸腺细胞球蛋白治疗再生障碍性贫血的荟萃分析。
Int J Hematol. 2017 May;105(5):578-586. doi: 10.1007/s12185-017-2179-3. Epub 2017 Jan 11.
3
Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.抗胸腺细胞球蛋白来源对重型再生障碍性贫血骨髓移植结局的影响。
Haematologica. 2017 Jul;102(7):1291-1298. doi: 10.3324/haematol.2017.164459. Epub 2017 Mar 24.
4
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum.用抗胸腺细胞球蛋白或抗淋巴细胞血清对再生障碍性贫血进行再治疗。
Am J Med. 1988 Apr;84(4):678-82. doi: 10.1016/0002-9343(88)90104-0.
5
Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.使用抗胸腺细胞球蛋白和环孢素对再生障碍性贫血进行免疫抑制治疗。
Semin Hematol. 2000 Jan;37(1):56-68. doi: 10.1016/s0037-1963(00)90030-1.
6
Refractory aplastic anemia: concomitant therapy with antithymocyte globulin and high-dose corticosteroids.难治性再生障碍性贫血：抗胸腺细胞球蛋白与大剂量皮质类固醇联合治疗
Am J Hematol. 1987 May;25(1):95-100. doi: 10.1002/ajh.2830250110.
7
Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.抗胸腺细胞球蛋白治疗老年获得性再生障碍性贫血患者的短期疗效及安全性
Br J Haematol. 2018 Feb;180(3):459-462. doi: 10.1111/bjh.14372. Epub 2016 Oct 7.
8
Horse versus rabbit antithymocyte globulin in aplastic anemia.再生障碍性贫血中马抗胸腺细胞球蛋白与兔抗胸腺细胞球蛋白的比较
N Engl J Med. 2011 Nov 10;365(19):1842-3; author reply 1843-4. doi: 10.1056/NEJMc1110228.
9
Antithymocyte globulin and cyclosporin: standard of care also for older patients with aplastic anemia.抗胸腺细胞球蛋白和环孢素：也是老年再生障碍性贫血患者的治疗标准。
Haematologica. 2019 Feb;104(2):215-216. doi: 10.3324/haematol.2018.207167.
10
Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.在严重再生障碍性贫血患者中比较马抗胸腺细胞球蛋白和兔抗胸腺细胞球蛋白时环孢素给药的混杂效应。
Haematologica. 2015 May;100(5):e211-2. doi: 10.3324/haematol.2014.122275.
引用本文的文献
1
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving T-cell Depletion Transplants and Long-Term Complications.接受T细胞去除移植的再生障碍性贫血患者的高总体生存率和无移植物抗宿主病生存率以及长期并发症
Blood Cell Ther. 2020 Jul 14;3(3):48-58. doi: 10.31547/bct-2020-001. eCollection 2020 Aug 25.
本文引用的文献
1
Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.抗胸腺细胞球蛋白来源对重型再生障碍性贫血骨髓移植结局的影响。
Haematologica. 2017 Jul;102(7):1291-1298. doi: 10.3324/haematol.2017.164459. Epub 2017 Mar 24.
2
Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.接受非亲缘骨髓移植的重型再生障碍性贫血患者的环磷酰胺预处理：一项1-2期剂量递减研究
Lancet Haematol. 2015 Sep;2(9):e367-75. doi: 10.1016/S2352-3026(15)00147-7. Epub 2015 Sep 2.
3
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.严重再生障碍性贫血中 HLA 全相合同胞供者与无关供者移植的当前结局：一项欧洲血液与骨髓移植组（EBMT）分析
Haematologica. 2015 May;100(5):696-702. doi: 10.3324/haematol.2014.115345. Epub 2015 Jan 23.
4
Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor.标准治疗：对于 HLA 匹配的同胞供者的 18-40 岁成年获得性 SAA 患者。
Bone Marrow Transplant. 2013 Feb;48(2):178-9. doi: 10.1038/bmt.2012.223. Epub 2012 Nov 19.
5
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.骨髓与外周血作为获得性再生障碍性贫血同胞移植的干细胞来源：骨髓在所有年龄组均具有生存优势。
Haematologica. 2012 Aug;97(8):1142-8. doi: 10.3324/haematol.2011.054841. Epub 2012 Feb 7.
6
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.阿仑单抗联合氟达拉滨和环磷酰胺可降低获得性再生障碍性贫血异基因造血干细胞移植后慢性移植物抗宿主病的发生率。
Blood. 2011 Aug 25;118(8):2351-7. doi: 10.1182/blood-2010-12-327536. Epub 2011 Apr 25.
7
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro.兔抗胸腺细胞球蛋白而非马抗胸腺细胞球蛋白可在体外促进功能性CD4+CD25高表达FOXP3+调节性T细胞的扩增。
Blood. 2008 Apr 1;111(7):3675-83. doi: 10.1182/blood-2008-01-130146. Epub 2008 Feb 4.
8
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.重度再生障碍性贫血的骨髓移植：预处理方案的随机对照研究
Blood. 2007 May 15;109(10):4582-5. doi: 10.1182/blood-2006-10-052308. Epub 2007 Feb 1.
9
Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.严重再生障碍性贫血患者接受基于抗体的免疫抑制方案后不同的EB病毒和巨细胞病毒激活模式
Blood. 2007 Apr 15;109(8):3219-24. doi: 10.1182/blood-2006-09-045625. Epub 2006 Dec 5.
10
A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells.抗胸腺细胞球蛋白的一种新作用机制：诱导CD4+CD25+Foxp3+调节性T细胞。
J Am Soc Nephrol. 2006 Oct;17(10):2844-53. doi: 10.1681/ASN.2006050422. Epub 2006 Aug 16.
Zotero 插件